Portfolio products
Buprenorphine HCl
CAS No.: 53152-21-9
Specification: Ph.Eur & USP
Regulatory Status: CEP + USDMF (applied)
Products under development
Naloxone
CAS No.: 357-08-4
Specification: Ph.Eur
Regulatory Status: N/A